Establishing a Pregnancy Lyme Disease Biobank
- 3 January 2024
- book chapter
- Published by Springer Nature
- Vol. 2742, 245-257
Abstract
Availability of relevant biological samples supports both basic science research and patient-centered clinical studies. Establishing a biorepository faces challenges at multiple levels. These tasks include defining mission definition and scope; selection of subjects and sample types; recruitment strategies; timing of collection in the patient’s journey; sample logistics and processing; determining what clinical data to collect; ensuring sample integrity on transport, processing, and storage; defining governance structures and oversight responsibilities; clarifying sample provenance and ownership; establishing procedures for sample and data access; selecting testing to be performed routinely versus upon request, and management of results; data security; funding sources; and regulatory compliance. Establishing and maintaining a biorepository therefore requires careful planning, diligent and sustained execution, technical and financial resources, stakeholder support, and flexible and resilient management to respond to changing environments and needs. Key words Biobank Biospecimen Pregnancy Neonatal Fetus Processing Compliance Human subjects Data bank OutcomesKeywords
This publication has 51 references indexed in Scilit:
- A Framework for Biobank SustainabilityBiopreservation and Biobanking, 2014
- “It’s my blood”: ethical complexities in the use, storage and export of biological samples: perspectives from South African research participantsBMC Medical Ethics, 2014
- Reframing the Influence of the Health Insurance Portability and Accountability Act on ResearchChest, 2012
- Power to the people: a wiki-governance model for biobanksGenome Biology, 2012
- Biobank governance: heterogeneous modes of ordering and democratizationJournal of Community Genetics, 2011
- “That's a good question”: University researchers' views on ownership and retention of human genetic specimensGenetics in Medicine, 2011
- Methods for the de-identification of electronic health records for genomic researchGenome Medicine, 2011
- The basics of preclinical drug development for neurodegenerative disease indicationsBMC Neurology, 2009
- Introduction to the Food and Drug Administration (FDA) Regulatory ProcessJournal of Proteome Research, 2005
- Attitudes of women to fetal tissue research.Journal of Medical Ethics, 1994